Iridium's good earnings news is even better news for Rocket Lab stock.

Rocket Lab celebrates another successful Electron mission. Neutron development faces a technical delay. Space systems and launch services remain central to growth. Satellite launch success, spacecraft ...

Rocket Lab (RKLB-5.51%), a developer of orbital rockets, shed over a fifth of its value in the week ending on Oct. 16, ...

The excitement around SpaceX’s June IPO did a lot of heavy lifting for space stocks well before the company actually listed. As the debut drew closer, investors ...

Rocket Lab Corporation is upgraded to Buy, while AST SpaceMobile remains a Sell, reinforcing the pair trade thesis after ...

Rocket Lab shares climbed 304.6% over those five years. That placed the stock far ahead of the typical company in its industry, which gained 58.8%. This industry figure, like the sector and all-stock ...

Neutron delay to 2027, dilution risks, and Iridium deal—yet strong margins, FCF growth, and defense tailwinds. See more here.

I will continue to hold RKLB. I am not in a rush to increase my position and will wait for the results of the space ...

Rocket Lab churns out "biggest ever" contracts like clockwork. Here's the latest.

Rick Orford reviews Rocket Lab’s business beyond launch, including Neutron, Space Systems, defense work and valuation risk after the stock’s move. He weighs the bull and bear cases for investors while ...

Rocket Lab's 98th Electron launch (Oct 23) delivered 3 satellites to orbit, marking its 19th mission of 2026 and third for HawkEye 360.

ARK Invest sold $5.8M in Alphabet while buying $34M of Rocket Lab stock after its Neutron rocket delay hit 2027.